The full-length sequence of a Papio anubis simian foamy provirus was obtained by using PCR followed by Sanger sequencing. This simian foamy virus from a P. anubis animal (SFVp.anubis) is 13,393 bp long. Like other proviruses, the genome of SFVp.anubis is organized with long terminal repeats (LTRs), as well as gag, pol, env, tas, and bet genes. SFVp.anubis is closer to Old World African strains than to New World ones.
S imilar to humans, nonhuman primates (NHPs) can be infected with the following three different families of exogenous retroviruses: simian immunodeficiency virus (SIV), simian T cell leukemia virus (STLV), and simian foamy virus (SFV), the counterparts of human immunodeficiency virus (HIV), human T cell leukemia virus (HTLV), and human foamy virus (HFV), respectively. However, and contrary to HIV and HTLV-1, the Spumavirus HFV is in fact still a simian virus, given the fact that it always originates from current contacts with NHPs and cannot be transmitted from human to human. SFV infection is asymptomatic, although a recent report described lower levels of hemoglobin in infected humans (1) . SFV seroprevalence can reach Ͼ75% in captive and wild NHPs (2) , and at least 31 and 45 NHP species are infected with STLV-1 and SIV, respectively (3, 4) . Since these three retroviruses have common modes of transmission, coinfections are frequent in NHPs and might have a biological impact (5) . As an example, it was recently shown that STLV-1/SFV natural coinfection leads to an increased SFV proviral load (6) . Only partial sequences of baboon SFV were previously reported (6) (7) (8) . Full-length foamy virus sequences obtained here from naturally infected captive baboons (Papio anubis housed at the primate center of the Centre National de la Recherche Scientifique [CNRS] [UPS 846] in Rousset-sur-Arc, France) will be useful for performing further investigation on coinfection consequences.
The use of animals was approved by the ethics committee (Autorisation de Projet Utilisant des Animaux à des Fins Scientifiques [APAFIS] number 4227-201604130940121) of the French Ministry of Higher Education, Research, and Innovation. The experimental procedure complied with current French laws and European directive 86/609/CEE. Animals were cared for in compliance with French regulations and were anesthetized with ketamine and medetomidine to allow blood draw. Peripheral blood mononuclear cells (PBMCs) were isolated by Ficoll gradient, washed, and lysed. Genomic DNA was extracted from PBMCs using a NucleoSpin tissue kit (Macherey-Nagel). The genomic DNA was then amplified by nested PCR using a series of long terminal repeats (LTRs), as well as gag, pol, env, and bet/tas primers (Table 1) . Based on a sequence comparison with SFV from the African green monkey (GenBank accession number MF582544) and guenon (GenBank accession number NC_043445), we ascertained that we had obtained a complete proviral sequence. The SFV strain V909/03F sequence is 13,393 bp long with a GC content of 37.84%. Using PCR products, each nucleotide was sequenced (Eurofins) at least twice on both strands. From the individual PCR product sequences, genome assembly was performed using Genome Compiler software (v2.2.88), NCBI BLASTN, and Clustal W for alignment and analyses. Thirty-five complete SFV sequences available in GenBank were used to make sequence comparisons. The genomic structure organization of V909/03F was similar to that of other SFVs, with the presence of LTRs and gag, pol, env, tas, and bet sequences. As expected, the genome of strain V909/03F is more closely related to Old World monkey SFV strains, in particular from African animals, than to strains from New World animals (Fig. 1) . The Pol amino acid sequence is the most conserved (up to 87% identity) between P. anubis and other animal species, while Tas and Bet in the closest strains are only 56% and 63% identical, respectively.
Data availability. The complete genome sequence of SFV V909/03F is available in GenBank under accession number MK241969.
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